Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Ellis

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 22, 2013
Understanding the needs of colorectal cancer patients during the pre-diagnosis phaseDavid Wiljer, Tara Walton, Julie Gilbert, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 PandemicKaren M Zhang, Som D Mukherjee, Gregory Pond, et al.
Clinical Lung Cancer|November 13, 2010
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancerCharles Butts, R Nevin Murray, Colum J Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysisDavid E Dawe, David Christiansen, Anand Swaminath, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Clinical Lung Cancer|June 24, 2015
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung CancerPeter M Ellis, Natasha B Leighl, Vera Hirsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancerAlberto A Chiappori, Peter M Ellis, John Turner Hamm, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosisRebecca G Hagerty, Phyllis N Butow, Peter M Ellis, et al.
Implementation Science : IS|March 25, 2014
A mixed methods approach to understand variation in lung cancer practice and the role of guidelinesMelissa C Brouwers, Julie Makarski, Kimberly Garcia, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|May 22, 2013
Understanding the needs of colorectal cancer patients during the pre-diagnosis phaseDavid Wiljer, Tara Walton, Julie Gilbert, et al.
Current Oncology (Toronto, Ont.)|September 27, 2024
Biopsychosocial Associates of Psychological Distress and Post-Traumatic Growth among Canadian Cancer Patients during the COVID-19 PandemicKaren M Zhang, Som D Mukherjee, Gregory Pond, et al.
Clinical Lung Cancer|November 13, 2010
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancerCharles Butts, R Nevin Murray, Colum J Smith, et al.
Lung Cancer (Amsterdam, Netherlands)|August 28, 2016
Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: A systematic review and meta-analysisDavid E Dawe, David Christiansen, Anand Swaminath, et al.
The Oncologist|April 24, 2023
Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on TrastuzumabShijie Zhou, Filipe Cirne, Justin Chow, et al.
Clinical Lung Cancer|June 24, 2015
A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung CancerPeter M Ellis, Natasha B Leighl, Vera Hirsh, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A phase I evaluation of oral CI-1033 in combination with paclitaxel and carboplatin as first-line chemotherapy in patients with advanced non-small cell lung cancerAlberto A Chiappori, Peter M Ellis, John Turner Hamm, et al.
Journal of Cancer Research and Clinical Oncology|July 12, 2011
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trialCharles Butts, Andrew Maksymiuk, Glenwood Goss, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 19, 2005
Communicating with realism and hope: incurable cancer patients' views on the disclosure of prognosisRebecca G Hagerty, Phyllis N Butow, Peter M Ellis, et al.
Implementation Science : IS|March 25, 2014
A mixed methods approach to understand variation in lung cancer practice and the role of guidelinesMelissa C Brouwers, Julie Makarski, Kimberly Garcia, et al.
Pageof 10